Navigation Links
Genelux Corporation Appoints Jodi Devlin as President
Date:1/12/2011

SAN DIEGO, Jan. 12, 2011 /PRNewswire/ -- Genelux Corporation, a privately held, San Diego-based biopharmaceutical company developing novel therapies against cancer, today announced that its Board of Directors has appointed Jodi Devlin as the company's President effective January 10, 2011.  Dr. Aladar Szalay, the company's Founder, will continue to serve as CEO and Chairman of the Board.

"Ms. Devlin is an excellent choice to lead Genelux Corporation into the next phase of growth, from commercializing the Company's leading cancer therapy to transforming the Company's operations accordingly," said Dr. Aladar Szalay, Founder, Chairman and CEO.  "She brings two decades of extensive commercialization and executive management experience at one of the world's leading pharmaceutical companies to Genelux and has the vision and energy to help us realize our goals."

Ms. Devlin's experience spans a broad range of functions including commercialization, clinical development, strategic business development and planning.  Most recently, Ms. Devlin served as Vice President at Abbott where she led Global Pipeline Marketing for all therapeutic areas, including oncology.  Over the course of her career, Ms. Devlin held positions as Vice President of International Marketing, U.S. Specialty Operations, Primary Care and Virology.  Under her leadership, HUMIRA®, Kaletra® and TriCor® all achieved multi-billion dollar status.  Ms. Devlin holds a BS in Nursing from the University of Oklahoma and an MBA from Washington University Olin School of Business.

"We are very pleased that Ms. Devlin will be joining our team at an exciting time in the company's evolution," said Dr. Szalay. "Her proven leadership and management capabilities have prepared her well for this new challenge.  She is a competent professional and knows how to bring a product successfully to market.  We believe she has the right combination of experie
'/>"/>

SOURCE Genelux Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Sigma-Aldrich Acquires Cerilliant Corporation to Strengthen its Analytical Chemistry Portfolio
2. Neogen Corporation Announces 2nd Quarter Results Conference Call
3. China Cord Blood Corporation to Hold Annual General Meeting in Hong Kong on February 18, 2011
4. China Cord Blood Corporation Announces Completion of Warrant Exchange
5. China Cord Blood Corporation Announces Participation at the 29th Annual J.P. Morgan Healthcare Conference
6. Intel Corporation acquires Toronto start-up CognoVision
7. Celladon Corporation Announces MYDICAR® Enzyme Replacement Therapy for Advanced Heart Failure Provides Sustained Clinical Improvements in Patients for 12 Months Compared with Placebo
8. Sigma-Aldrich Corporation Announces Death of Chairman and CEO; Election of New CEO and Chairman; Conference Call Scheduled for 10:00a.m. (Central Time) on November 15, 2010
9. International Technidyne Corporation Acquired by Warburg Pincus
10. Omeros Corporation Awarded $1.7 Million in Grants Under the Qualifying Therapeutic Discovery Project Program
11. NEURO-BIOTECH CORPORATION: Updates and latest developments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... July 24, 2014 Draper University, ... is proud to announce that for 6 weeks ... countries will converge on the Draper University campus ... intensive, experiential program focused on entrepreneurship, building real-world ... school, currently running its sixth cohort, continues to ...
(Date:7/23/2014)... YORK , July 24, 2014 ... Immune Pharmaceuticals Inc. (OTCQX and NASDAQ OMX First ... "Immune" or "the Company"), announced a collaboration to ... pemphigoid last night at an event attended by ... interested parties. Lyfebulb is a health and wellness ...
(Date:7/23/2014)... Dresden-Rossendorf (HZDR), the Vienna University of Technology and ... embedding nearly perfect semiconductor crystals into a silicon ... nanowires, very fast and multi-functional processing units can ... future. The research results will be published in ... are considered the cornerstone of future chip technology, ...
(Date:7/23/2014)... DENVER , July 23, 2014  Having the ... making is vital to accelerating business growth and achieving ... American Hospital Association (AHA) Leadership Summit, July 20-22, 2014, ... prestigious panel of hospital executives and healthcare experts discussing ... Joanne Carrocino , President & Chief Executive Officer ...
Breaking Biology Technology:Summer Entrepreneurship Program Kicked Off by Draper University in Silicon Valley 2Summer Entrepreneurship Program Kicked Off by Draper University in Silicon Valley 3Innovative Collaboration To Increase Awareness Of Bullous Pemphigoid, A Rare Autoimmune Disease Of The Skin 2Innovative Collaboration To Increase Awareness Of Bullous Pemphigoid, A Rare Autoimmune Disease Of The Skin 3Innovative Collaboration To Increase Awareness Of Bullous Pemphigoid, A Rare Autoimmune Disease Of The Skin 4Innovative Collaboration To Increase Awareness Of Bullous Pemphigoid, A Rare Autoimmune Disease Of The Skin 5A crystal wedding in the nanocosmos 2MSC and Cape Regional Medical Center Partner to Improve Cost, Quality and Outcomes 2
... plc,(LSE: SHP, NASDAQ: SHPGY) the global specialty biopharmaceutical ... Standards ("IFRS") for the twelve months to December ... announced its results for the same period,under US ... Shire,s strategic goal is to become the ...
... IRVINE, Calif., March 25 Masimo (Nasdaq:,MASI), ... Motion and Low,Perfusion pulse oximetry, today announced ... manufacturer and supplier of,electrocardiographs, spirometers, patient monitors ... SET technology platform as,the foundational technology of ...
... NEOG ) announced today that its net income for ... increased 34% from the previous year,s third,quarter. Net income ... share,compared to the prior year,s $1,990,000 ($0.14 per share). ... 2008 fiscal year increased 31%,to $8,923,000 from $6,822,000 in ...
Cached Biology Technology:Shire plc: IFRS Results for the Year Ending December 31, 2007 2Shire plc: IFRS Results for the Year Ending December 31, 2007 3Shire plc: IFRS Results for the Year Ending December 31, 2007 4Shire plc: IFRS Results for the Year Ending December 31, 2007 5Shire plc: IFRS Results for the Year Ending December 31, 2007 6Shire plc: IFRS Results for the Year Ending December 31, 2007 7Shire plc: IFRS Results for the Year Ending December 31, 2007 8Shire plc: IFRS Results for the Year Ending December 31, 2007 9Shire plc: IFRS Results for the Year Ending December 31, 2007 10Shire plc: IFRS Results for the Year Ending December 31, 2007 11Shire plc: IFRS Results for the Year Ending December 31, 2007 12Shire plc: IFRS Results for the Year Ending December 31, 2007 13Shire plc: IFRS Results for the Year Ending December 31, 2007 14Shire plc: IFRS Results for the Year Ending December 31, 2007 15Shire plc: IFRS Results for the Year Ending December 31, 2007 16Shire plc: IFRS Results for the Year Ending December 31, 2007 17Shire plc: IFRS Results for the Year Ending December 31, 2007 18Shire plc: IFRS Results for the Year Ending December 31, 2007 19Shire plc: IFRS Results for the Year Ending December 31, 2007 20Shire plc: IFRS Results for the Year Ending December 31, 2007 21Shire plc: IFRS Results for the Year Ending December 31, 2007 22Shire plc: IFRS Results for the Year Ending December 31, 2007 23Shire plc: IFRS Results for the Year Ending December 31, 2007 24Shire plc: IFRS Results for the Year Ending December 31, 2007 25Shire plc: IFRS Results for the Year Ending December 31, 2007 26Shire plc: IFRS Results for the Year Ending December 31, 2007 27Shire plc: IFRS Results for the Year Ending December 31, 2007 28Shire plc: IFRS Results for the Year Ending December 31, 2007 29Shire plc: IFRS Results for the Year Ending December 31, 2007 30Shire plc: IFRS Results for the Year Ending December 31, 2007 31Shire plc: IFRS Results for the Year Ending December 31, 2007 32Shire plc: IFRS Results for the Year Ending December 31, 2007 33Schiller AG Adopts Masimo Rainbow SET as Their Technology Platform of Choice for Patient Monitoring Devices Worldwide 2Schiller AG Adopts Masimo Rainbow SET as Their Technology Platform of Choice for Patient Monitoring Devices Worldwide 3Schiller AG Adopts Masimo Rainbow SET as Their Technology Platform of Choice for Patient Monitoring Devices Worldwide 4
(Date:7/24/2014)... . , Electric cars ... common sight on the roads of the Scandinavian country ... new vehicle registrations for the second time. This poses a ... claim only a small portion of the market. Of the ... mere 8000 are electric powered. The main factors discouraging motorists ...
(Date:7/23/2014)... 24, 2014 Pfenex Inc. (NYSE MKT: PFNX) today ... shares of its common stock at a price to the ... the underwriters a 30-day option to purchase up to 1,250,000 ... price. The shares are expected to begin trading on the ... William Blair & Company, L.L.C. and ...
(Date:7/23/2014)... (SMU) The U.S. Department of Defense recently ... a $2.6 million grant to support its goal ... fields. STEMPREP recruits bright, science-minded minority middle school ... STEMPREP project, then provides high school students with ... based at SMU,s Annette Caldwell Simmons School of ...
Breaking Biology News(10 mins):Nano-supercapacitors for electric cars 2Nano-supercapacitors for electric cars 3Pfenex Inc. Announces Pricing Of Initial Public Offering 2Department of Defense awards $2.6 million grant to SMU STEM program for minority students 2
... April 11, 2011 (BRONX, NY) Just as inhaling ... it. Two researchers at Albert Einstein College of Medicine ... grant from the National Institutes of Health to clinically develop ... before the cancer becomes malignant and spreads. The grant ...
... SEATTLE, Wash.April 12, 2011The Allen Institute for Brain ... genomically comprehensive human brain map, a previously unthinkable ... than four years of rigorous studies and documentation. ... Allen Human Brain Atlas, an online public resource ...
... material available to identify persons or find next of kin ... the kits usually employed to carry out DNA identifications do ... is not available, and that which is available is highly ... persons from these small fragments of DNA. His thesis, presented ...
Cached Biology News:NIH funds investigation of inhaled lung cancer treatment 2Allen Institute for Brain Science announces first comprehensive gene map of the human brain 2Allen Institute for Brain Science announces first comprehensive gene map of the human brain 3Developing a tool for identification -- even using very degraded DNA samples 2Developing a tool for identification -- even using very degraded DNA samples 3